K2 Oncology
PrivateLast Round
Series B
Aug 4, 2022
Total Funding Raised
$1.5M
Company Overview
K2 Oncology operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in August 2022.
K2 Oncology is a biotechnology company that specializes in organoid technology, providing anti-tumor drug R&D services and precision medicine solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
K2 Oncology Comparables
Compare K2 Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AimingMed | 89% | |
| D1 Medical Technology | 88% | |
| bioGenous Biotechnology | 87% |
For institutional investors. Book with your work email.
K2 Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 4, 2022 | ||||
| Series A | Aug 1, 2018 | ||||
| Angel | Sep 1, 2016 |
For institutional investors. Book with your work email.
K2 Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delian Capital | Series A |
| Tongsheng Capital | Series A |
| Zhongguancun Development Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2022
Completed a Series B funding round.
- Aug 1, 2018
Led by Delian Capital with participation from Tongsheng Capital and Zhongguancun Development Group.
For institutional investors. Book with your work email.
K2 Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about K2 Oncology's valuation, stock price, and market status.
Is K2 Oncology a public or private company?
K2 Oncology is a private company.
What is the current stock price of K2 Oncology?
K2 Oncology is a private company, so its shares have no public market price. Caplight tracks K2 Oncology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is K2 Oncology worth (valuation)?
Valuation information for K2 Oncology is not publicly available.
Can I buy K2 Oncology stock?
K2 Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was K2 Oncology's last funding round?
K2 Oncology's most recent funding round was Series B on August 4, 2022.
Who are the main investors in K2 Oncology?
Key investors in K2 Oncology include Delian Capital.
Will K2 Oncology IPO soon?
No public IPO plans have been announced for K2 Oncology.
How can I track K2 Oncology secondary market activity?
Caplight tracks bids, offers, and trades in K2 Oncology's shares on secondary markets.